These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11750385)

  • 1. A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy.
    Mahalati K; Kahan BD
    Transplant Proc; 2001; 33(7-8):3232-3. PubMed ID: 11750385
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen.
    Kahan BD; Podbielski J; Schoenberg L
    Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors.
    Langer RM; Hong DM; Katz SM; Van Buren CT
    Transplant Proc; 2002 Dec; 34(8):3162-4. PubMed ID: 12493406
    [No Abstract]   [Full Text] [Related]  

  • 4. Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: interim analysis after 3 months.
    Vester U; Kranz B; Wehr S; Boger R; Hoyer PF;
    Transplant Proc; 2002 Sep; 34(6):2209-10. PubMed ID: 12270366
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.
    Citterio F; Sparacino V; Altieri P; Rigotti P; Calabrese S; Poli M; Vinti V; Segoloni GP
    Transplant Proc; 2005 Mar; 37(2):827-9. PubMed ID: 15848545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients.
    Hricik DE
    Transplant Proc; 2003 May; 35(3 Suppl):73S-78S. PubMed ID: 12742471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus rescue therapy for refractory rejection in renal transplant recipients.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK; Chueh SC; Hu RH; Lee PH
    J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
    Pliszczynski J; Kahan BD
    Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-a-day administration of everolimus, cyclosporine, and steroid after renal transplantation: a review of the rationale.
    Corbetta G; Ponticelli C
    Transplant Proc; 2010 May; 42(4):1303-7. PubMed ID: 20534286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus versus calcineurin inhibitor-based immunosuppressive therapy in kidney transplantation: a 4-year follow-up.
    Nafar M; Alipour B; Ahmadpoor P; Pour-Reza-Gholi F; Samadian F; Samavat S; Farhangi S
    Iran J Kidney Dis; 2012 Jul; 6(4):300-6. PubMed ID: 22797101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant.
    Ruiz JC; Campistol JM; Mota A; Prats D; Gutiérrez A; Castro A; Pinto JR; García J; Morales JM; Grinyo JM; Arias M
    Transplant Proc; 2002 Feb; 34(1):92-3. PubMed ID: 11959199
    [No Abstract]   [Full Text] [Related]  

  • 14. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapamycin reduces rejection in heart transplant recipients.
    Radovancevic B; El-Sabrout R; Thomas C; Radovancevic R; Frazier OH; Van Buren C
    Transplant Proc; 2001; 33(7-8):3221-2. PubMed ID: 11750381
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus permits steroid withdrawal from a cyclosporine regimen.
    Mahalati K; Kahan BD
    Transplant Proc; 2001; 33(1-2):1270. PubMed ID: 11267287
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid withdrawal in renal transplantation treated with cyclosporine a: long-term evolution.
    Gómez E; Laurés A; Pobes A; Baltar J; Portal CG; Navascúes R
    Transplant Proc; 2001; 33(7-8):3263-4. PubMed ID: 11750397
    [No Abstract]   [Full Text] [Related]  

  • 20. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine.
    Ponticelli C; Tarantino A; Aroldi A; Sparacino V; Stefoni S; Citterio F; Duca L; Scolari MP; Calabrese S; Altieri P; Civati G; Cesana B
    Transplant Proc; 2003 May; 35(3 Suppl):62S-63S. PubMed ID: 12742469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.